SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 488 filers reported holding SEAGEN INC in Q1 2021. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $34,888,278 | +7.1% | 164,451 | -2.8% | 0.02% | +13.6% |
Q2 2023 | $32,572,124 | -49.7% | 169,241 | -47.0% | 0.02% | -52.2% |
Q1 2023 | $64,709,008 | +41.4% | 319,598 | -10.3% | 0.05% | +35.3% |
Q4 2022 | $45,762,926 | +14.3% | 356,104 | +21.7% | 0.03% | +6.2% |
Q3 2022 | $40,043,000 | -14.5% | 292,650 | +10.5% | 0.03% | -8.6% |
Q2 2022 | $46,858,000 | +85.2% | 264,824 | +50.8% | 0.04% | +118.8% |
Q1 2022 | $25,295,000 | +1.2% | 175,592 | +8.6% | 0.02% | +6.7% |
Q4 2021 | $25,007,000 | -10.5% | 161,753 | -1.8% | 0.02% | -16.7% |
Q3 2021 | $27,956,000 | +6.0% | 164,637 | -1.4% | 0.02% | +5.9% |
Q2 2021 | $26,373,000 | +49.3% | 167,046 | +31.3% | 0.02% | +41.7% |
Q1 2021 | $17,669,000 | -16.6% | 127,245 | +5.2% | 0.01% | -25.0% |
Q4 2020 | $21,180,000 | – | 120,930 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 47,288,259 | $7,465,870,000 | 32.79% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 145,000 | $22,868,000 | 6.04% |
Lagoda Investment Management, L.P. | 59,780 | $9,438,000 | 4.40% |
Avidity Partners Management LP | 640,000 | $101,043,000 | 2.73% |
PFM Health Sciences, LP | 482,985 | $76,254,000 | 2.39% |
Boxer Capital, LLC | 400,000 | $63,152,000 | 2.23% |
Redmile Group, LLC | 771,385 | $121,786,000 | 1.80% |
Woodline Partners LP | 577,655 | $91,200,000 | 1.70% |
Rhenman & Partners Asset Management AB | 157,925 | $24,933,000 | 1.69% |
Parkman Healthcare Partners LLC | 45,176 | $7,132,000 | 1.56% |